Holen Sie sich die Stockscreener-App
79.52
0.55%
-0.265
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$79.78
Offen:
$79.93
24-Stunden-Volumen:
694.52K
Relative Volume:
0.25
Marktkapitalisierung:
$37.34B
Einnahmen:
$5.56B
Nettoeinkommen (Verlust:
$247.25M
KGV:
150.28
EPS:
0.5291
Netto-Cashflow:
$1.24B
1W Leistung:
+1.72%
1M Leistung:
+12.96%
6M Leistung:
+24.72%
1J Leistung:
+23.40%
1-Tages-Spanne:
$79.26
$80.00
1-Wochen-Bereich:
$78.19
$80.50
52-Wochen-Spanne:
$56.68
$80.50
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Vergleichen Sie VTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
79.50 | 37.48B | 5.56B | 247.25M | 1.24B | 0.5291 |
|
WELL
Welltower Inc
|
194.96 | 135.60B | 9.90B | 967.82M | 1.88B | 1.3269 |
|
OHI
Omega Healthcare Investors Inc
|
44.70 | 13.18B | 1.08B | 448.00M | 779.91M | 1.61 |
|
DOC
Healthpeak Properties Inc
|
17.59 | 12.09B | 2.80B | 279.29M | 1.20B | 0.40 |
|
AHR
American Healthcare Reit Inc
|
47.51 | 8.71B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Baird Adjusts Price Target on Ventas to $90 From $76, Maintains Outperform Rating - MarketScreener
Top 2 Real Estate Stocks You May Want To Dump This Month - Benzinga
Ventas (VTR): Assessing Valuation Following Recent 14% Monthly Share Price Gain - Yahoo Finance
Bulgarelli of Ventas sells $400k in stock By Investing.com - Investing.com Nigeria
Bulgarelli of Ventas sells $400k in stock - Investing.com
Ventas Insider Sold Shares Worth $400,205, According to a Recent SEC Filing - MarketScreener
Liquidity Mapping Around (VTR) Price Events - news.stocktradersdaily.com
Why Ventas Inc. stock stays on top picksQuarterly Earnings Report & Reliable Price Breakout Signals - newser.com
Will Ventas Inc. (VEN) stock sustain uptrend momentumPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Why Ventas Inc. stock is favored by pension fundsJuly 2025 Recap & Advanced Technical Signal Analysis - newser.com
How Ventas Inc. stock reacts to Fed tightening2025 Market Outlook & Verified Swing Trading Watchlist - newser.com
How Ventas Inc. (VEN) stock benefits from digital adoptionJuly 2025 Short Interest & AI Driven Stock Reports - newser.com
Analyzing recovery setups for Ventas Inc. investorsJuly 2025 Retail & Verified Chart Pattern Trade Signals - newser.com
Will Ventas Inc. stock reach Wall Street targetsDividend Hike & Weekly High Return Stock Forecasts - newser.com
Ventas Inc(VTR.US) Officer Sells US$3.26 Million in Common Stock - 富途牛牛
Will Ventas Inc. (VEN) stock profit from fiscal stimulusJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Published on: 2025-11-19 14:13:10 - newser.com
Can Ventas Inc. (VEN) stock double in coming years2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Can Ventas Inc. (VEN) stock sustain double digit ROE - newser.com
Why Ventas Inc. (VEN) stock stays on top picksQuarterly Investment Review & Real-Time Buy Zone Alerts - newser.com
How buyback programs support Ventas Inc. (VEN) stockMarket Activity Recap & Daily Technical Forecast Reports - newser.com
Will Ventas Inc. (VEN) stock benefit from infrastructure bill2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Will Ventas Inc. stock outperform Nasdaq indexJuly 2025 Technicals & Low Risk Entry Point Guides - newser.com
Is Ventas Inc. stock in buy zone after pullbackIPO Watch & Weekly Top Stock Performers List - newser.com
Can Ventas Inc. (VEN) stock retain market dominance2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Forecasting Ventas Inc. price range with options dataJuly 2025 Final Week & Safe Entry Trade Signal Reports - newser.com
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
3.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):